Latest News and Press Releases
Want to stay updated on the latest news?
-
HOUSTON, July 22, 2021 (GLOBE NEWSWIRE) -- Asylia Therapeutics (“Asylia”), a development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune diseases,...
-
HOUSTON, May 25, 2021 (GLOBE NEWSWIRE) -- Asylia Therapeutics, Inc. (“Asylia”), a development-stage biotechnology company advancing novel immune modulating therapies for cancer and autoimmune...